GlassScriptPhysician profile
Vishal Arora
NPI 1538371802
$22,392.93
in general payments reported to CMS, 2019-2025
46 companies · $6,169 in 2025
The $6,169 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,090 · 2020: $3,176 · 2021: $1,858 · 2022: $1,992 · 2023: $3,519 · 2024: $3,589 · 2025: $6,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,277 · Travel and Lodging: $3,375 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,277.42 |
| Travel and Lodging | $3,374.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,402.32 | 2022-2025 | Ekosonic, General - Therapies, General - Stents |
| Medtronic Vascular, INC. | $2,561.31 | 2019-2020 | |
| Inari Medical, INC. | $2,281.37 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $2,234.74 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan, Micra |
| Bayer Healthcare Pharmaceuticals INC. | $1,892.29 | 2025 | |
| Edwards Lifesciences Corporation | $1,334.98 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $1,256.76 | 2020-2025 | Impella |
| Amgen INC. | $895.26 | 2019-2025 | Repatha, Repatha, Prolia |
| Shockwave Medical, INC | $782.49 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $630.55 | 2019-2025 | Cardiomems, Coroflow, Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $578.67 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $573.27 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $376.54 | 2020-2024 | Andexxa |
| Penumbra, INC. | $330.77 | 2023-2025 | Indigo System, Ruby Coil, Penumbra System |
| Novartis Pharmaceuticals Corporation | $327.01 | 2019-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.39 | 2019-2024 | Jardiance |
| Stryker Corporation | $314.56 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $251.79 | 2019-2025 | Cardiva Vascade 6/7f Vcs, Optowire |
| Cvrx, INC. | $228.94 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $228.53 | 2021-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $186.29 | 2022-2025 | Camzyos |
| United Therapeutics Corporation | $174.00 | 2024 | |
| Endologix LLC | $137.69 | 2025 | Endocross Device, Torus Stent Graft System |
| Angiodynamics, INC. | $123.39 | 2019-2022 | |
| Cardiovascular Systems INC. | $122.02 | 2020-2023 | Diamondback Coronary |
| Lilly USA, LLC | $120.66 | 2023-2025 | Mounjaro, Zepbound |
| Aidoc Medical LTD | $114.00 | 2023 | Briefcase |
| Recor Medical INC | $94.24 | 2025 | Paradise Ultrasound Renal Denervation System |
| Vital Connect, INC | $80.25 | 2023-2025 | Vitalpatch Rtm |
| Pfizer INC. | $70.01 | 2019-2025 | |
| Biotronik INC. | $48.78 | 2019-2023 | Orsiro Mission, Nhancer Rx |
| Terumo Medical Corporation | $47.49 | 2019-2024 | Angio-Seal, Metacross Otw, Glidesheath Slender |
| Teleflex LLC | $40.21 | 2023-2025 | Guideliner |
| Kiniksa Pharmaceuticals International, Plc | $39.39 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $30.66 | 2025 | Amvuttra |
| Idorsia Pharmaceuticals US INC | $24.74 | 2024 | Quviviq |
| Inspire Medical Systems, INC. | $21.14 | 2023 | Inspire |
| Chiesi USA, INC. | $20.22 | 2022 | |
| Heartflow, INC. | $19.67 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.54 | 2021 | |
| Abbvie INC. | $13.88 | 2019 | |
| Cleerly, INC. | $13.78 | 2023 | Cleerly Labs |
| Kiniksa Pharmaceuticals, LTD. | $13.76 | 2023 | Arcalyst |
| W. L. Gore & Associates, INC. | $13.58 | 2024 | Gore Cardioform Septal Occluder |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.